Carissa Chan Hsu is a pharmacist who is specialized in Oncology in West Hollywood, California. Patients can reach her at 8700 Beverly Blvd, West Hollywood or contact her on 310-423-0633. Active license number of Carissa Chan Hsu is 69254 for Oncology in California. Carissa Chan Hsu is a licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Complete Profile:
Carissa Chan Hsu speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Carissa Chan Hsu
Specialization:
Oncology
Credentials:
PHARMD
Gender:
Female
Location:
8700 Beverly Blvd, West Hollywood, California, 90048-1804
Phone:
310-423-0633
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Carissa Chan Hsu are as mentioned below.
NPI Number:
1487202347
NPI Enumeration Date:
03 Sep, 2019
NPI Last Update On:
03 Sep, 2019
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Carissa Chan Hsu are as mentioned below.
Specialization
License Number
State
Status
Oncology
69254
California
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
8700 Beverly Blvd, West Hollywood, California
Zip:
90048-1804
Phone Number:
310-423-0633
Fax Number:
--
Patients can reach Carissa Chan Hsu at 8700 Beverly Blvd, West Hollywood, California or can call on phone at 310-423-0633.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.